Last Updated: September 24, 2026

Sinotherapeutics Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SINOTHERAPEUTICS INC

SINOTHERAPEUTICS INC has five approved drugs.

There are three tentative approvals on SINOTHERAPEUTICS INC drugs.

Summary for Sinotherapeutics Inc

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5

Drugs and US Patents for Sinotherapeutics Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sinotherapeutics Inc	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	216001-001	Sep 30, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sinotherapeutics Inc	PROPAFENONE HYDROCHLORIDE	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	210339-002	Jan 4, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sinotherapeutics Inc	MESALAMINE	mesalamine	TABLET, DELAYED RELEASE;ORAL	217337-001	May 12, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sinotherapeutics Inc	PROPAFENONE HYDROCHLORIDE	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	210339-003	Jan 4, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sinotherapeutics Inc	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	208652-001	Aug 21, 2017	AB3	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sinotherapeutics Inc	POSACONAZOLE	posaconazole	TABLET, DELAYED RELEASE;ORAL	212411-001	Aug 21, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Sinotherapeutics Inc

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.